Boaquina, Jacky Lyn B.

HRN: 24-31-95  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/04/2024
01/11/2024
IV
2.25g
Q6hrs
Septic Shock 2 Infected Breast Mass
Waiting Final Action 
01/04/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/04/2024
01/11/2024
IV
600mg
Q8hrs
Infected Breast Mass
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: